From May 1990 to August 1991, 36 patients admitted to the Department of Internal Medicine in a medical school hospital with hematological malignancies or solid tumors, developed respiratory tract colonization with Pseudomonas cepacia. Sixteen (44.4%) of these patients developed pneumonia, and four (11.1%) died of respiratory failure due to P. cepacia pneumonia. Extensive survey of the hospital environment as well as equipment showed that nebulizer devices used by the patients for inhalation were contaminated with P. cepacia. Phenotypic characteristics, (production of hemolysin and extracelluler enzymes [lipase, lecithinase and protease]), the Analytical Profile Index 20 NE pattern, and the pattern of DNA fingerprinting by pulse-field gel electrophoresis in clinically isolated strains and strains derived from nebulizer devices were compared. The strains of P. cepacia obtained from patients in the Department of Internal Medicine were indistinguishable from each other and also from those isolated from nebulizer devices, but were different from those isolated from patients in other departments at the same time. These results demonstrated that the outbreak of P. cepacia respiratory colonization in immunocompromised patients was a nosocomial acquisition, and probably occurred by transmission through contaminated nebulizer devices.
Background
There are 41 beds on the 4th floor East of a medical school hospital in Shikoku Island, Japan. From May 1990 to August 1991, 285 patients were admitted to the 4th floor East (the First Department of Internal Medicine). In this period, the upper respiratory tract of 36 patients (12.6%) were colonized by P. cepacia. The organism was isolated from pharyngeal swabs, mouthwash solutions, sputum samples, and tongue swabs from these patients. Blood culture was positive for P. cepacia in only one case. All patients were receiving one or more antibiotics when the organism was initially isolated. Sixteen (44%) of these patients developed pneumonia, and P. cepacia was isolated from their sputa. Among them four patients (11%) died of respiratory failure caused by pneumonia. The mean age of these patients was 53 years (range 17-81) and all of them were immunocompromised with hematological malignancies or solid tumors.
In November 1990, we became aware of an unusually high number of upper respiratory tract cultures positive for P. cepacia, which had rarely been isolated before (Fig. 1 ). There had been no change in the laboratory technique that might account for the increase. We therefore suspected that this event was a nosocomial outbreak, and started to collect P. cepacia isolates after December 1990 for further investigation. During the same time, the upper respiratory tracts of some patients admitted to the Department of Neurosurgery or to the Department of Orthopedics (Intensive Care Units or 5th floor East) were also colonized by P. cepacia. We included the isolates from these patients in the present study to analyze the outbreak on the 4th floor East. When multiple isolates were received from the same patient, only the first isolate was used for the investigation. Outbreak of Pseudomonas cepacia Respiratory Infection Table 1 Origins of P. cepacia strains used in this study
The patient was first admitted to the ICU, and was then transferred to the 4th floor East.
Bacterial strains
The strains of P. cepacia used in this study are shown in Table 1 . Fifteen strains were from the upper respiratory tract of patients on the 4th floor East (the Department of Internal Medicine) who suffered from respiratory disorders such as pharyngitis (KF2, KF4, KF6, KF16, KF17, KF18, KF19), bronchitis (KF7 and KF20), or pneumonia (KF1, KF3, KF5, KF8, KF9, KF15). Three strains were isolated from sputum of patients with similar disorders in the ICU (KF10, KF11, KF12), three strains from those on the 5th floor East (KF13, KF21, KF22), and one strain (KF14) from vaginal swab of a patient with vaginitis in the outpatient clinic. Each of the eight strains with KN numbers was from a nebulizer device used by the patients on the 4th floor East. Two reference strains in our laboratory stock (strains JN25 and JN106) were also used to determine the phenotype and DNA fingerprinting patterns. JN106, showed the same API 20 NE pattern, which was similar to that of KF14 but different from those of other strains. Strain JN25 produced no extracellular products, whereas strain JN106 produced all extracellular products tested for. The DNA fingerprinting pattern of P. cepacia by PFGE is shown in Fig. 2 and 3 . Figure 2 (A) shows that strains KF1 through KF9 have identical Xba I sites (Type I), and that strains KF10 through KF13 have a common profile (Type II) differing from that of Type I. On the other hand, KF14, which was obtained from the outpatient clinic, has a unique pattern (Type III). Strains JN25 and JN106 have patterns similar to each other but different from other strains (Type IV). Figure 2 (B) shows that strainsKF15, KF16, KF18, KF19, and KF20 are of the Type I profile, whereas KF17, KF21, and KF22 are Type II. It also shows that KN1, KN2, and KN3, isolated from nebulizer devices, are Type I. These results were confirmed by the DNA fingerprinting patterns of selected P. cepacia strains digested with restriction endonuclease Ase I (Fig. 3) . The results of PFGE typing, summarized in Table 3 , clearly demonstrate that all the strains except KF17 isolated from patients and nebulizer devices on the 4th floor East had an identical DNA fingerprinting pattern. In addition, the fingerprinting patterns of KF17 and strains from the 5th floor East (KF13, KF21, KF22) were identical to that of the strains from the ICU (KF10, KF11, KF12). These results as well as the phenotypic profiles of these strains suggest a common origin, possibly the ICU, because they were isolated from the patients who had once been in the ICU and were then transferred to either the 4th floor East (KF17 colonizer) or to the 5th floor East.
Discussion
This investigation showed that the strains of P. cepacia that colonized the upper respiratory tract of patients admitted to the 4th floor East were indistinguishable from each other in their phenotypes as well as DNA fingerprinting patterns. By an extensive survey, we were able to isolate P. cepacia from nebulizer devices on the 4th floor East which had been used for inhalation of antibiotics for prophylactic purposes, because these patients were immunocompromised with hematological malignancies or solid tumors. The isolates from the nebulizer devices were also indistinguishable from those from patients who had shared these devices. Therefore the outbreak of P. cepacia infection in the 4th floor East was a nosocomial acquisition and probably occurred by transmission through contaminated nebulizer devices.
Isolation of P. cepacia from clinical specimens and the hospital environment, particularly from wet surfaces, equipment, pharmaceutical solutions, and antiseptics, has become increasingly common, and the presence of P. cepacia in these areas has been shown to lead to colonization and infection5, 25, 26) . P. cepacia has been considered to have low virulence, and most clinical isolations are not associated with symptoms. Randa1126) warned, however, that P. cepacia could become a potentially lethal pathogen in a compromised patient. In such patients, it is a cause of bacteremia and is highly resistant to antimicrobial therapy. This observation has subsequently been confirmed in several centers in North America14,16,18)-21) which have noted an increasing percentage of P. cepacia in respiratory tract cultures from patients with cystic fibrosis.
The high risk of P. cepacia colonization among persons whose siblings had P. cepacia colonization or those attending hospital outpatient clinics suggests that P. cepacia may be transmitted from person to person either directly20) or via a vehicle"). However, attempts to identify the source and the mode of transmission of P. cepacia among patients with cystic fibrosis have so far been unsuccessful16,18)- 21, 27, 28) .
In the present study, P. cepacia was shown to originate from a nebulizer device. Although these nebulizer devices had been checked for bacterial contamination every three months, no bacteria had been detected, probably due to an improper method. In the past, we carried out a wiping test instead of pouring culture medium directly into the nebulizer chamber as we did in this study.
Before October 1991, when we isolsted P. cepacia from nebulizer devices, the chambers of the device had been routinely soaked in 0.1% sodium hypochlorite solution for more than 30 min without disassembling it. A test for sensitivity of isolated strains of P. cepacia to sodium hypochlorite revealed that the bacteria suspended in the sodium hypochlorite solution were killed within 30 seconds (data not shown). Therefore, it is probable that once the bacteria got into the chamber of the device the migrated to a region where they escaped from the disinfectant. Therefore the method of disinfection previously carried out was not appropriate for the intricate plastic nebulizer device.
The method of disinfection of nebulizer devices was changed as follows: the devices were disassembled and disinfected with sodium hypochlorite every day, and sterilized by autoclaving once a week. In addition, we changed the use of nebulizer devices from sharing to individual use to prevent cross-infection. after we changed the method of disinfection, only one patient on the 4th floor East developed respiratory tract colonization with P. cepacia (Fig. 1) . However, this strain produced hemolysin, and therefore must be different from the previously prevailing strain.
The exceptional phenotypic profile and DNA fingerprinting pattern of strain KF17 from a patient in a ward on the 4th floor East can be explained by the fact that this patient was transferred from the ICU, suggesting that colonization by P. cepacia had already been established in the ICU.
New methods have been developed for typing bacteria, including plasmid analysis6), comparison of DNA fingerprinting patterns by PFGE29), and ribotyping17,27,29,30,31). Rabkin et al. 30 ) compared ribotyping with several other methods for typing P. cepacia to determine the relationships among isolates involved in an outbreak. They concluded that ribotyping, serotyping, and biochemical testing are all useful. Anderson et al.29) confirmed the clinical utility of DNA fingerprinting by PFGE as well as ribotyping in classifying isolates of P. cepacia involved in an outbreak. Our study also demonstrated the utility of DNA fingerprinting by PFGE combined with phenotypic analysis. 
